BioCentury
ARTICLE | Clinical News

Matritech preclinical data

May 30, 2005 7:00 AM UTC

In 298 blinded serum samples, the qualitative RT-PCR test to detect nuclear matrix protein NMP66 identified over 70% of the cancer sera. The colorimetric assay showed good differentiation of noncancer...